Prevalence and risk factors for age-related cataract in Sweden

References

• Khairallah M, Kahloun R, Bourne R, Limburg H, Flaxman SR, Jonas JB, et al. Number of people blind or visually impaired by cataract worldwide and in world regions, 1990 to 2010. Invest Ophthalmol Vis Sci. 2015;56:6762–9.
   PubMed Web of Science ®Google Scholar
• National Quality Register for Cataracts. 2019 Aug 8. Available at: http://kvalitetsregister.se/englishpages/findaregistry/registerarkivenglish/nationalqualityregistryforcataracts.2150.html
   Google Scholar
• Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al. The Framingham eye study monograph. Surv Ophthalmol. 1980;24:350–65.
   Web of Science ®Google Scholar
• Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population: The Beaver Dam Eye Study. Ophthalmology 1992;99:546–52.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Cumming RG, Attebo K, Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology 1997;104:581–8.
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Linton KL, Magli YL, Neider MW. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology 1990;97:1428–33.
   PubMed Web of Science ®Google Scholar
• Chylack LT, Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The lens opacities classification system III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831–6.
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto RD, Podgor MJ, Wilson PW, Ferris FL 3rd, Colton T, et al. Cigarette smoking and the risk of developing lens opacities. The Framingham studies. Arch Ophthalmol. 1997;115:1113–8.
   PubMed Web of Science ®Google Scholar
• Lindblad BE, Håkansson N, Svensson H, Philipson B, Wolk A. Intensity of smoking and smoking cessation in relation to risk of cataract extraction: a prospective study of women. Am J Epidemiol. 2005;162:73–9.
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: The Beaver Dam Eye Study. Am J Ophthalmol. 1998;126:782–90.
   PubMed Web of Science ®Google Scholar
• West SK, Duncan DD, Muñoz B, Rubin GS, Fried LP, Bandeen-Roche K, et al. Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation project. JAMA 1998;280:714–8.
   PubMed Web of Science ®Google Scholar
• Hiller R, Podgor MJ, Sperduto RD, Nowroozi L, Wilson PW, D'Agostino RB, et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 1998;105:1244–50.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology 2009;116:652–7.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Jonasson F, Kojima M, Katoh N, Ono M, Takahashi N, et al. The Reykjavik Eye Study-prevalence of lens opacification with reference to identical Japanese studies. Ophthalmologica. 2000;214:412–20.
   PubMed Web of Science ®Google Scholar
• Xu L, Cui T, Zhang S, Sun B, Zheng Y, Hu A, et al. Prevalence and risk factors of lens opacities in urban and rural Chinese in Beijing. Ophthalmology 2006;113:747–55.
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol. 1986;124:916–25.
   PubMed Web of Science ®Google Scholar
• McCarty CA, Mukesh BN, Fu CL, Taylor HR. The epidemiology of cataract in Australia. Am J Ophthalmol. 1999;128:446–65.
   PubMed Web of Science ®Google Scholar
• Younan C, Mitchell P, Cumming RG, Rochtchina E, Wang JJ. Myopia and incident cataract and cataract surgery: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci. 2002;43:3625–32.
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto RD, Krueger DE. Pseudoexfoliation, intraocular pressure, and senile lens changes in a population-based survey. Arch Ophthalmol. 1982;100:1080–2.
   PubMedGoogle Scholar
• Arvind H, Raju P, Paul PG, Baskaran M, Ve Ramesh S, George RJ, et al. Pseudoexfoliation in South India. Br J Ophthalmol. 2003;87:1321–3.
   PubMed Web of Science ®Google Scholar
• Ekström C, Botling Taube A. Pseudoexfoliation and cataract surgery: a population-based 30-year follow-up study. Acta Ophthalmol. 2015;93:774–7.
   PubMed Web of Science ®Google Scholar
• Ekström C. Prevalence of open-angle glaucoma in central Sweden. The Tierp Glaucoma Survey. Acta Ophthalmol Scand. 1996;74:107–12.
   PubMedGoogle Scholar
• Östberg A, Löth A, Gustafson D, Lindblom B. Skövde Cataract study: I. Prevalence of lens opacities in a Swedish community. Ophthalmology 2006;113:970–5.
   PubMed Web of Science ®Google Scholar
• Hirvelä H, Luukinen H, Laatikainen L. Prevalence of risk factors of lens opacities in the elderly in Finland. Ophthalmology 1995;102:108–5.
   PubMed Web of Science ®Google Scholar
• Olafsdottir E, Andersson DKG, Stefánsson E. The prevalence of cataract in a population with and without type 2 diabetes mellitus. Acta Ophthalmol. 2012;90:334–40.
   PubMed Web of Science ®Google Scholar
• Jaskiran K, Kukreja S, Kaur A, Malhotra N, Kaur R. The oxidative stress in cataract patient. J Clin Diagn Res 2012;6:1629–32.
   PubMedGoogle Scholar
• Klein BE, Klein R, Ritter LL. Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol. 1994;112:85–91.
   PubMed Web of Science ®Google Scholar
• Worzala K, Hiller R, Sperduto RD, Mutalik K, Murabito JM, Moskowitz M, et al. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies. Arch Intern Med. 2001;161:1448–54.
   PubMed Web of Science ®Google Scholar
• Škiljić D, Petersen A, Jan-Olof Karlsson J-O, Behndig A, Nilsson S, Zetterberg M. Effects of 17β-estradiol on activity, gene and protein expression of superoxide dismutases in primary cultured human lens epithelial cells. Curr Eye Res. 2018;43:639–46.
   PubMed Web of Science ®Google Scholar
• Ejdervik Lindblad BE, Håkansson N, Philipson B, Wolk A. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women. Ophthalmology 2010;117:424–30.
   PubMed Web of Science ®Google Scholar
• Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016;123:1036–42.
   PubMed Web of Science ®Google Scholar
• Arnarsson A, Jonasson F, Sasaki H, Ono M, Jonsson V, Kojima M, et al. Reykjavik Eye Study Group. Risk factors for nuclear lens opacification: the Reykjavik Eye Study. Dev Ophthalmol. 2002;35:12–30.
   PubMedGoogle Scholar